CARDINAL: A Phase 1 study of TERN-701, a novel investigational allosteric BCR::ABL1 inhibitor for patients with previously treated CML - Jabbour, Elias; Hughes, Timothy; Van Etten, Richard; Andorsky, David; Carreno, Gonzalo; Le Coutre, Philipp; Jamy, Omer; Giraldo, Pilar; Kim, Dong-Wook; Oehler, Vivian; Hochhaus, Andreas; Cortes, Jorge; et al. (Blood, 2025)